Sophie Brayne

Sophie Brayne has a diverse work experience in business development and consulting roles in the biotech and pharmaceutical industries. Sophie is currently the Director of Business Development at Quell Therapeutics, where they are responsible for implementing academic/industry collaborations and strategic partnerships. Prior to this role, they served as the Associate Director of Business Development at Quell, where they contributed to the company's business operations and strategy development.

Before joining Quell Therapeutics, Sophie worked as a Business Development Manager at Cell Medica, focusing on in-licensing and out-licensing efforts for the company's cancer immunotherapy platform. Sophie also played a key role in conducting competitive intelligence monitoring and supporting alliance negotiations.

Prior to their roles in the biotech industry, Sophie worked at IP Pragmatics Ltd as a Consultant and later as a Business Development Manager. Sophie also gained experience as an Intellectual Property Intern at Bird & Bird LLP and completed a Marketing Strategic Initiatives Internship at Pfizer.

Sophie started their career as a Science Policy Adviser Intern at the Society of Biology. Overall, they possess a strong background in business development, strategic partnerships, and consulting in the biotech and pharmaceutical industries.

Sophie Brayne completed their Master of Business Administration (MBA) degree with a focus on Innovation & Entrepreneurship at Imperial College London from 2017 to 2019. Prior to that, they pursued a Bachelor's degree in Biological Sciences with a specialization in Pharmacology at The University of Edinburgh from 2007 to 2011. Additionally, Sophie also obtained another Master of Business Administration (MBA) degree at Imperial College Business School, although the specific years of study and field of study for this degree are not provided.